Find uplifting stories about heroes, innovations, and solutions
1185 results for "rsv vaccine"
After Western Australia's worst flu season on record, the state is rolling out free RSV vaccines to protect 15,000 older residents in aged care facilities. The $2.6 million program could save lives and prevent hospital overcrowding this winter.
A new vaccine given to pregnant mothers is slashing dangerous RSV hospitalizations in newborns by nearly 70%, offering protection from birth when babies are most vulnerable. This breakthrough could save thousands of infants from severe respiratory illness every year.
A vaccine given during pregnancy is slashing hospital admissions for newborns with dangerous chest infections by more than 80%. The breakthrough is protecting thousands of vulnerable babies from a virus that sends over 20,000 infants to UK hospitals each year.
The American College of Physicians just issued new guidelines that could prevent thousands of deaths among older adults. A simple, one-time vaccine now recommended for everyone 75 and older offers powerful protection against a virus that hospitalizes 170,000 seniors annually.
A new maternal vaccine is keeping thousands of Australian babies out of hospitals, with protection strongest during their most vulnerable first weeks of life. Real-world data shows the program is working even better than expected.
A new vaccine program for pregnant mothers and newborns has slashed serious respiratory virus hospitalizations in Australian babies by nearly half. The results show vaccinated babies are up to 90% less likely to need hospital care. #
Major medical groups and insurers are stepping up to ensure Americans can still get flu, COVID-19, and RSV vaccines this fall, even as federal vaccine guidance remains disrupted. The rollout is expected to be smooth and similar to last year.
Nova Scotia's new RSV vaccination program for infants and seniors is showing real results just months after launch. The province reports significant drops in respiratory illness hospitalizations among the most vulnerable.
A breakthrough antibody shot is protecting infants from severe RSV with stunning effectiveness, offering parents powerful new tools just as the respiratory virus peaks across the country. Recent studies show the protection may last even longer than expected.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
When the government went quiet on vaccine guidance this year, America's leading medical organizations stepped up with their own science-backed recommendations. Five major health groups joined forces to help families make informed decisions about flu, COVID, and RSV shots.
A routine vaccine millions get for shingles might be doing something remarkable: protecting hearts for years afterward. New research on 70,000 Americans reveals an unexpected health bonus that could change how we think about vaccines.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
Showing 20 of 1185